To further elucidate the role of NAT10 in HCC progression and assess whether SMAD3 functions as a downstream mediator, we performed SMAD3 rescue assays in SK‐HEP‐1 and HCCLM3 cells following NAT10 knockdown (Figure 6A). Here, NAT10 is linked to hepatocellular carcinoma.